Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CYTOVAC A/S
A/S
Bankrupt
Advertising protection
CVR 31262666
Frederiksgade 19, 1265
København K
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2008 · 18 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CYTOVAC A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2019
1M
2020
1M
2021
0M
2022
0M
2023
EBITDA
DKK millions
0M
-12M
-24M
-36M
-48M
-38M
2019
-14M
+63%
2020
-13M
+7%
2021
-10M
+23%
2022
-12M
-20%
2023
Income statement
DKK thousands
Item
2019
2020
2021
2022
2023
Revenue
—
1.000
960
0
—
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-37.591
-13.507
-13.049
-10.043
-12.227
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-37.591
-13.507
-13.049
-10.043
-12.227
Net financials
-2.051
-4.319
-1.993
2.342
-4.893
Profit before tax
-39.642
-17.826
-15.042
-7.701
-17.120
Tax
-5.500
-2.130
-1.690
-1.424
-1.801
Net profit
-34.142
-15.696
-13.352
-6.277
-15.319
Balance sheet
DKK thousands
Item
2019
2020
2021
2022
2023
Total assets
7.504
3.513
2.976
3.225
6.427
Equity
-37.935
-53.631
-66.983
-73.260
-88.579
Long-term debt
0
0
619
639
662
Short-term debt
45.439
57.144
69.339
75.845
94.345
Total debt
45.439
57.144
69.339
76.484
95.007
Financial ratios
5-year trend
EBITDA margin
-1222700000.0%
This company
15.8%
Market median
-7738607695% vs market
2019
2023
Equity ratio
-1378.2%
This company
38.2%
Market median
-3708% vs market
2019
2023
Return on equity
-1531900000.0%
This company
18.4%
Market median
-8325543578% vs market
2019
2023
Net profit margin
-1531900000.0%
This company
8.1%
Market median
-18912345779% vs market
2019
2023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2019
2023
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
2019
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
More on CYTOVAC A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
